Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)

被引:502
作者
Finberg, Karin E. [1 ,13 ]
Heeney, Matthew M. [2 ,13 ]
Campagna, Dean R. [3 ]
Aydinok, Yesim [4 ]
Pearson, Howard A. [5 ]
Hartman, Kip R. [6 ]
Mayo, Mary M. [7 ]
Samuel, Stewart M. [8 ]
Strouse, John J. [9 ]
Markianos, Kyriacos [10 ,11 ]
Andrews, Nancy C. [11 ,13 ]
Fleming, Mark D. [12 ]
机构
[1] Massachusetts Gen Hosp, Pathol Serv, Boston, MA 02114 USA
[2] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[3] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] Ege Univ, Fac Med, Dept Pediat Hematol, TR-35100 Izmir, Turkey
[5] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA
[6] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA
[7] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA
[8] Pediat Hlth Associates PC, New York, NY 11803 USA
[9] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA
[10] Childrens Hosp, Program Genom, Boston, MA 02115 USA
[11] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[12] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[13] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA
关键词
D O I
10.1038/ng.130
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Iron deficiency is usually attributed to chronic blood loss or inadequate dietary intake. Here, we show that iron deficiency anemia refractory to oral iron therapy can be caused by germline mutations in TMPRSS6, which encodes a type II transmembrane serine protease produced by the liver that regulates the expression of the systemic iron regulatory hormone hepcidin. These findings demonstrate that TMPRSS6 is essential for normal systemic iron homeostasis in humans.
引用
收藏
页码:569 / 571
页数:3
相关论文
共 10 条
[1]  
Andrews NC, 1997, YALE J BIOL MED, V70, P219
[2]   HEME METABOLISM AND INVITRO ERYTHROPOIESIS IN ANEMIA ASSOCIATED WITH HYPOCHROMIC MICROCYTOSIS [J].
BROWN, AC ;
LUTTON, JD ;
PEARSON, HA ;
NELSON, JC ;
LEVERE, RD ;
ABRAHAM, NG .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 27 (01) :1-6
[3]   MALABSORPTION AND DEFECTIVE UTILIZATION OF IRON IN 3 SIBLINGS [J].
BUCHANAN, GR ;
SHEEHAN, RG .
JOURNAL OF PEDIATRICS, 1981, 98 (05) :723-728
[4]  
Hartman KR, 1996, AM J HEMATOL, V51, P269, DOI 10.1002/(SICI)1096-8652(199604)51:4<269::AID-AJH4>3.0.CO
[5]  
2-U
[6]   Mass spectrometry-based hepcidin measurements in serum and urine: Analytical aspects and clinical implications [J].
Kemna, Erwin H. J. M. ;
Tjalsma, Harold ;
Podust, Vladimir N. ;
Swinkels, Dorine W. .
CLINICAL CHEMISTRY, 2007, 53 (04) :620-628
[7]  
Mayo M M, 2001, Clin Lab Sci, V14, P135
[8]   Regulation of iron metabolism by hepcidin [J].
Nemeth, Elizabeta ;
Ganz, Tomas .
ANNUAL REVIEW OF NUTRITION, 2006, 26 :323-342
[9]   Ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption [J].
Pearson, HA ;
Lukens, JN .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (05) :412-417
[10]   RETRACTED: Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins (Retracted Article) [J].
Velasco, G ;
Cal, S ;
Quesada, V ;
Sánchez, LM ;
López-Otín, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) :37637-37646